Android Apple

Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results

By Yahoo! Finance   |   3 months ago
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results

Meridian Funds, managed by ArrowMark Partners, outperformed the Russell 2500 Growth Index in Q2 2024. The top holding, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), showed promising growth potential with a one-month return of 1.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.